查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586221

脑脊髓液管理市场：按产品、最终用户划分 - 全球预测 2025-2030 年

Cerebral Spinal Fluid Management Market by Product (CSF Drainage, CSF Shunts), End-User (Adult, Geriatric, Pediatric) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脑脊髓液管理市场价值为16.3亿美元，预计到2024年将达到17.3亿美元，复合年增长率为6.23%，预计到2030年将达到24.9亿美元。

脑脊髓液 (CSF) 管理包括调节脑脊髓液的产生、循环和吸收的技术和设备，以解决水脑症和颅内压波动等问题。对脑脊髓液管理的迫切需求源自于脑脊髓液在保护脑部、清除废弃物和维持颅内压方面的作用。应用范围涵盖神经病学、神经外科和小儿科，分流器和外部引流系统等设备用于医院和医疗机构。脑脊髓液分流系统的技术进步、神经系统疾病盛行率的增加以及易患神经退化性疾病的老年人口的增加推动了市场成长。机会在于开发微创手术技术，结合物联网和人工智慧来监测和管理脑脊髓液动态，以及改善患者的治疗结果。然而，仍存在限制可及性的挑战，包括与分流故障相关的併发症、感染疾病和手术干预的高成本。此外，市场面临严格的监管要求和缓慢的核准流程，这可能会阻碍创新产品的推出。一个重要的创新领域是探索用于分流开发的生物可吸收材料，减少长期併发症。此外，应用人工智慧主导的演算法进行即时监测和预测分析有可能显着改善临床决策。企业需要专注于与研究机构的策略伙伴关係关係，以推动创新并快速确保监管合规性。该市场的特点是现有医疗设备公司竞争激烈，新参与企业需要透过技术创新和改进的客户支援服务来脱颖而出。注重研发和了解当地市场动态对于在不断变化的环境中抓住机会至关重要。总体而言，脑脊髓液管理的未来在于技术与医学的无缝集成，以提供高效、经济高效且对患者友好的解决方案。

主要市场统计
基准年[2023] 16.3亿美元
预测年份 [2024] 17.3亿美元
预测年份 [2030] 24.9亿美元
复合年增长率（%） 6.23%

市场动态：揭示快速发展的脑脊髓液管理市场的关键市场洞察

供需的动态交互作用正在改变脑脊髓液管理市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 水脑症和神经系统疾病的盛行率增加
    • 增加每个国家获得更高品质医疗保健服务的机会
    • 政府努力改善医疗基础设施
  • 市场限制因素
    • 手术费用高
  • 市场机会
    • 脑脊髓液管理的技术进步与发展
    • 快速投资正在进行的脑屏障和脑液研究计划
  • 市场挑战
    • 世界各地缺乏熟练的医疗保健专业人员

波特五力：驾驭脑脊髓液管理市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对脑脊髓液管理市场的外部影响

外部宏观环境因素在塑造脑脊髓液管理市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解脑脊髓液管理市场的竞争格局

脑脊髓液管理市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵脑脊髓液管理市场供应商的绩效评估

FPNV 定位矩阵是评估脑脊髓液管理市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了脑脊髓液管理市场的成功之路

脑脊髓液管理市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中水脑症和神经系统疾病的盛行率不断增加
      • 扩大整个经济领域获得更高品质医疗保健服务的机会
      • 政府努力改善医疗基础设施
    • 抑制因素
      • 手术费用高
    • 机会
      • CSF 管理的技术进步与发展
      • 快速投资正在进行的与脑屏障和脑液相关的研究计划
    • 任务
      • 全球缺乏熟练的医疗保健专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脑脊髓液管理市场：副产品

  • 脑脊髓液引流
  • 脑脊髓液分流术

第七章脑脊髓液管理市场：依最终使用者分类

  • 成人用
  • 老年病
  • 小儿科

第八章美洲脑脊髓液管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区脑脊髓液管理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的脑脊髓液管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • B. Braun SE
  • BeckerSmith Medical, Inc.
  • BIcakcIlar TIbbi Cihazlar Sanayi ve Ticaret AS
  • Delta Surgical
  • DESU MEDIKAL AS
  • G.Surgiwear Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Medix Corporation
  • Lyfboat Technologies Pvt. Ltd.
  • Medtronic PLC
  • Moller Medical GmbH
  • Natus Medical Incorporated
  • SALVAVIDAS PHARMACEUTICAL PVT. LTD
  • Siemens AG
  • SOPHYSA SA
  • Spiegelberg GmbH & Co. KG
Product Code: MRR-AD36CD898157

The Cerebral Spinal Fluid Management Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.73 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 2.49 billion by 2030.

Cerebral Spinal Fluid (CSF) management involves techniques and devices that regulate the production, circulation, and absorption of cerebral spinal fluid, addressing conditions like hydrocephalus and intracranial pressure fluctuations. The critical necessity for CSF management arises from its role in cushioning the brain, removing waste, and maintaining intracranial pressure. Its applications span across neurology, neurosurgery, and pediatrics, with devices like shunts and external drainage systems being used in hospitals and healthcare facilities. Market growth is propelled by technological advancements in CSF shunt systems, increasing prevalence of neurological disorders, and a rising geriatric population prone to neurodegenerative diseases. Opportunities lie in the development of minimally invasive surgical techniques and the incorporation of IoT and AI to monitor and manage CSF dynamics, enhancing patient outcomes. However, challenges persist, including complications related to shunt malfunction, infections, and the high cost of surgical interventions, which can limit accessibility. Furthermore, the market faces stringent regulatory requirements and a slow approval process that can hinder the introduction of innovative products. A significant area of innovation is the exploration of bioresorbable materials for shunt development, reducing long-term complications. In addition, the application of AI-driven algorithms for real-time monitoring and predictive analytics could dramatically improve clinical decision-making. Companies must focus on strategic partnerships with research institutions to drive innovation and secure regulatory compliance swiftly. The market is characterized by intense competition with the presence of established medical device firms, requiring new entrants to differentiate through technological innovation and improved customer support services. Emphasizing R&D and understanding regional market dynamics are crucial for capturing opportunities in this evolving landscape. Overall, the future of CSF management lies in the seamless integration of technology and medicine to provide efficient, cost-effective, and patient-friendly solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.73 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 6.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebral Spinal Fluid Management Market

The Cerebral Spinal Fluid Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of hydrocephalus and neurological disorders among population
    • Increasing access to better quality healthcare services across economies
    • Government initiative to improve healthcare infrastructure
  • Market Restraints
    • High cost of surgical procedures
  • Market Opportunities
    • Technological advancements and developments in CSF management
    • Rapid investments in ongoing research projects related to brain barriers and brain fluids
  • Market Challenges
    • Dearth of skilled healthcare professionals worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Cerebral Spinal Fluid Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebral Spinal Fluid Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebral Spinal Fluid Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebral Spinal Fluid Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebral Spinal Fluid Management Market

A detailed market share analysis in the Cerebral Spinal Fluid Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebral Spinal Fluid Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebral Spinal Fluid Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebral Spinal Fluid Management Market

A strategic analysis of the Cerebral Spinal Fluid Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebral Spinal Fluid Management Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, BeckerSmith Medical, Inc., BIcakcIlar TIbbi Cihazlar Sanayi ve Ticaret A.S., Delta Surgical, DESU MEDIKAL A.S., G.Surgiwear Ltd., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kaneka Medix Corporation, Lyfboat Technologies Pvt. Ltd., Medtronic PLC, Moller Medical GmbH, Natus Medical Incorporated, SALVAVIDAS PHARMACEUTICAL PVT. LTD, Siemens AG, SOPHYSA SA, and Spiegelberg GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Cerebral Spinal Fluid Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across CSF Drainage and CSF Shunts.
  • Based on End-User, market is studied across Adult, Geriatric, and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of hydrocephalus and neurological disorders among population
      • 5.1.1.2. Increasing access to better quality healthcare services across economies
      • 5.1.1.3. Government initiative to improve healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of surgical procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and developments in CSF management
      • 5.1.3.2. Rapid investments in ongoing research projects related to brain barriers and brain fluids
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled healthcare professionals worldwide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cerebral Spinal Fluid Management Market, by Product

  • 6.1. Introduction
  • 6.2. CSF Drainage
  • 6.3. CSF Shunts

7. Cerebral Spinal Fluid Management Market, by End-User

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Americas Cerebral Spinal Fluid Management Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cerebral Spinal Fluid Management Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cerebral Spinal Fluid Management Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun SE
  • 2. BeckerSmith Medical, Inc.
  • 3. BIcakcIlar TIbbi Cihazlar Sanayi ve Ticaret A.S.
  • 4. Delta Surgical
  • 5. DESU MEDIKAL A.S.
  • 6. G.Surgiwear Ltd.
  • 7. Integra LifeSciences Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. Kaneka Medix Corporation
  • 10. Lyfboat Technologies Pvt. Ltd.
  • 11. Medtronic PLC
  • 12. Moller Medical GmbH
  • 13. Natus Medical Incorporated
  • 14. SALVAVIDAS PHARMACEUTICAL PVT. LTD
  • 15. Siemens AG
  • 16. SOPHYSA SA
  • 17. Spiegelberg GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBRAL SPINAL FLUID MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF DRAINAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023